Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited. Fokas E, Smith JJ, Garcia-Aguilar J, Glynne-Jones R, et al. J Clin Oncol 2024;42:872-875.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fokas E, Smith JJ, Garcia-Aguilar J, Glynne-Jones R, et al. Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited. J Clin Oncol 2024;42:872-875.
PMID: 37890124